Andrew Dudum, Chief Executive Officer at Hims & Hers Health, Inc. (HIMS), sold 200,670 shares at $49.43 ($9.9M) on 2025-07-21, disclosed to the SEC on 2025-07-23.
Scheduled sale ($9.9M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.41 | 16,667 | $824K | 8.3% |
| 2 | $49.41 | 16,667 | $824K | 8.3% |
| 3 | $49.43 | 17,001 | $840K | 8.5% |
| 4 | $49.43 | 17,001 | $840K | 8.5% |
| 5 | $49.56 | 41,667 | $2.1M | 20.8% |
| 6 | $49.56 | 41,667 |
| $2.1M |
| 20.8% |
| 7 | $49.60 | 50,000 | $2.5M | 25.0% |
| Total | $49.52 avg | 200,670 | $9.9M | 100% |
| Filing → |
| HIMS | SELL | 2025-09-17 | $18.8M | — | Filing → |
| HIMS | SELL | 2025-08-20 | $13.6M | — | Filing → |
| HIMS | SELL | 2025-08-11 | $33.4M | — | Filing → |